RxDoctor Payments Data

Darrell Hanson, MD

Orthopaedic Surgery · Houston, TXNPI 1487689147

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $207,277 of the $284,178 with a category attached, or 72.9%. Depuy Synthes Products, Inc. accounts for 72.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $142,651 and has fallen 98.9% since, to $1,518 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$284,178in general payments, 2019–2025

Across 178 payments — averaging $1596.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$207K
  • Medtronic$48K
  • Zimmer Biomet$10K
  • Medical Device Business Services, Inc.$8K
  • Johnson & Johnson$4K
  • Globus Medical$2K
  • plus $4K from 21 others

What the payments were for

  • Royalty or licence$207,27773%
  • Consulting fees$19,7487%
  • Speaking & faculty fees$39,42414%
  • Travel & lodging$5,2792%
  • Food & beverage$12,4504%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$284,178 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$130,735
Medicare patients
160
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib32$2,253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$229
Gabapentin17$203
Meloxicam24$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →